Comparison of the modulatory effects of human and rat liver microsomal metabolism on the estrogenicity of bisphenol A: Implications for extrapolationto humans
R. Elsby et al., Comparison of the modulatory effects of human and rat liver microsomal metabolism on the estrogenicity of bisphenol A: Implications for extrapolationto humans, J PHARM EXP, 297(1), 2001, pp. 103-113
Citations number
40
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Bisphenol A [BPA, 2,2-bis(4-hydroxyphenyl)propane], a xenoestrogen, is a mo
nomer for the synthesis of polycarbonate plastics, epoxy resins, and compos
ites. Metabolism of BPA to the monoglucuronide will determine the extent of
its estrogenicity in vivo. Investigation of the metabolism of BPA (500 muM
) by isolated female rat hepatocytes confirmed the formation of BPA glucuro
nide as the major metabolite. There was a significant difference (p < 0.05)
between the V-max (mean +/- S.E.M., n = 4) of glucuronidation by pooled ma
le or female human (four livers in each case) and immature female rat liver
microsomes (5.9 +/- 0.4, 5.2 +/- 0.3, and 31.6 +/- 8.1 nmol/min/mg of prot
ein, respectively). Estrogenic activity of BPA, assessed in a coupled micro
somal metabolism-yeast estrogenicity assay, was decreased 3- and 7- fold fo
llowing glucuronidation by human female and immature female rat liver micro
somes, respectively. Incubations of BPA with pooled human or rat liver micr
osomes, in the presence of NADPH, resulted in the formation of 5-hydroxybis
phenol A [2-(4,5-dihydroxyphenyl)-2-(4-hydroxyphenyl) propane], which was 1
0-fold less potent than BPA in the yeast estrogenicity assay. However, ther
e was insufficient turnover to achieve a significant effect on the estrogen
ic activity of BPA. Because human liver microsomes did not glucuronidate BP
A as extensively as the rat liver microsomes, estrogen target tissues in hu
mans may be subject to greater exposure to BPA than the tissues of the imma
ture female rats used for assessing estrogenicity of xenobiotics.